Search

everythinglearnresearchcommunity

for

Search:↓

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Finasteride effectively reduces excess hair in women with certain conditions.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Treat hirsutism in premenopausal women with oral contraceptives and consider additional treatments if needed.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Women also use 5α-reductase inhibitors for hair loss and hirsutism.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Hirsutism affects many women and is managed with a combination of medical treatments and hair removal, tailored to individual needs.

Hormone therapy might help improve women's appearance as they age.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Females with 5 alpha-reductase-2 deficiency have less body hair, no acne, normal fertility, and delayed menarche.

Adding estrogen increased bone mass in a transsexual man undergoing hormone therapy.

Hirsutism in young women is often caused by PCOS and managed with lifestyle changes, treatments, and hormonal therapy, which takes 9-12 months to work.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Estetrol may help prevent hair loss and support hair growth in women.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

The treatment successfully lowered testosterone levels and reduced symptoms.

Hormone replacement therapy improves skin health and reduces aging signs in postmenopausal women.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.